Placental stem cell exosomes injected into the brain after a large stroke
Dehghani L et al., International Journal of Preventive Medicine, 2022
Safety only
Safety only: The study looked for harms. It was not designed to show whether the treatment works.
Level 3 of 5: Treated patients were compared with a control: placebo, another treatment, or the untreated side of the face. Most exosome trials at this level are small and short.
See the full key- Design
- Pilot randomized trial, safety focus
- People
- 5 treated patients
- Made from
- Placenta
- How it was given
- Injected into brain tissue during decompressive craniectomy
What they found
No bleeding, excess swelling, or other adverse effects at the injection site.
What limits it
Designed to test safety in very few patients. It cannot show whether recovery improved.